Cargando…
SCIG administration: A promising and patient convenient alternative for those receiving long-term IVIG
Background: Intravenous immunoglobulin (IVIG) therapy has been used as antibody replacement therapy in primary immunodeficiency diseases (PID) for more than 50 years. In this study, we aimed to define IVIG usage and adverse reactions and complications in PID and explain how subcutaneous immunoglobul...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
HBKU Press
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284658/ https://www.ncbi.nlm.nih.gov/pubmed/35909401 http://dx.doi.org/10.5339/qmj.2022.fqac.29 |